Advertisement

Topics

Companies Related to "2018 Italy Oncology Testing Market Shares Sales Segment" [Most Relevant Company Matches] RSS

20:34 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "2018 Italy Oncology Testing Market Shares Sales Segment" found in our extensive corporate database of over 50,000 company records.

Showing "2018 Italy Oncology Testing Market Shares Sales Segment" Companies 1–25 of 7,300+

Relevant

MEDTOX Scientific

MEDTOX Scientific, Inc. is engaged throughout the United States in two distinct, but related businesses-the manufacturing and distribution of diagnostic drug screening devices (the Diagnostic segment), and forensic and clinical laboratory services to corporations, pharmaceutical companies and health care organizations (the Laboratory segment). Through its MEDTOX Diagnostics segment in Burlington, ...


Ipsen

Ipsen is a global biopharmaceutical group with total sales in excess of 1 billion euros in 2009, and total worldwide staff of more than 4,400. Its strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology, and primary care drugs, which significantly contribute to research financing. This strategy is also su...

Ipsen N.A.

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2013. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by 3 franchises: neurology, endocrinology and urology-oncology. Moreover, the Group has an act...


Ipsen S.A.

Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 contribute to the discovery and development of innovative drugs for patient care. Ipsen’s development strategy is based on fast growing specialty care drugs in oncology, endocrin...

Resaphene Suisse AG

Resaphene Suisse AG was founded in 2015 with the aim of developing a tinnitus therapy device with funds from the incubator of BS Health Group AG. After the prototype was available at the beginning of 2016, series production was started. In the meantime, 2 series have been successfully placed on the market. In June 2018, the company was listed on the Vienna ...

STADA Arzneimittel AG

STADA - Generics with “value for money” Generics contributed 73.2% to sales in 2006 (previous year: 74.3%) and represents STADA’s largest core segment by far. In 2006, sales in the generics core segment rose by 20% to EUR 911.2 million (2005: EUR 759.3 million1)). A part of this growth is based on the acquisition of the Serbian Hemofarm, whose product portfolio includes approx. 75% of gener...

Nerviano Medical Sciences

Nerviano Medical Sciences (NervianoMS) is the largest pharmaceutical R&D facility in Italy and one of the largest oncology-focused, integrated discovery and development companies in Europe. NervianoMS was incorporated in May 2004 following company re-organisation by Pfizer.A total of almost 700 highly skilled and experienced scientists, technicians and managers are involved in oncology R&D project...

ISAGRO S.P.A

Formed in 1992, Isagro SpA is the company at the head of a group that, in a little more than 10 years, has become a highly qualified operator at world level in the agrochemicals sector. Isagro is the only group in Italy that invests directly in innovation and the development of new molecules; is active in research, development, production, marketing and distribution of proprietary crop protection ...

Squeeze Report Inc.

The short data is downloaded from Finras’ Reg SHO Daily Files and the quote data is downloaded from Quote Media daily. The Estimated Shares Shorted is the amount of shares our algorithm estimates is still short. The Estimated Shares Covered is the amount of shares our algorithm estimates has been covered. The Estimated Shares Still Short is the differ...

Allergy Therapeutics

Allergy Therapeutics®. (AT) is a Europe-based specialty pharmaceutical company focused upon the treatment and prevention of allergy. AT has an existing sales base of approximately £19m/€27m per annum, an MHRA-approved manufacturing capability and an established sales and marketing infrastructure in several major European markets. In addition, the Company has a number of novel compounds which h...

Innogenetics Group

Innogenetics is a Belgium-based international biopharmaceutical company that applies its knowhow and synergies in molecular biology, immunology, and virology to build two distinct businesses: a specialty diagnostics business dedicated to the value-added, clinically targeted integration of diagnostics and therapeutics to improve the real-time treatment of disease, and a therapeutics business that d...

Cristalia

Founded in 1972, Cristália was firstly engaged in Psychiatry, supplying drugs to clinics, hospitals, and mainly to government bodies. A few years later, by focusing on the hospital segment, Cristália became the pioneer producer of anesthetics and adjuvants. Still engaged in the hospital market, it approached a new segment in pain management by launching narcotic analgesic drugs.

SGS SA

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With 43'000 employees, SGS operates a network of about 1’000 offices and laboratories around the world.Originally founded in 1878 in Rouen as French grain shipment inspection house, the Company was registered in Geneva as Société Génér...

DiaTech Oncology

DiaTech Oncology is a privately held clinical pathology laboratory that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s...

SurGenTec LLC

SurGenTec is an ISO 13485 certified medical device manufacturer based out of Boca Raton, FL. The company develops innovative products focused on minimally invasive surgical solutions. SurGenTec was recently awarded the 2018 Spine Technology Award presented at NASS for their ALARA Access Needle. This new technology will be released in early December 2018. The ...

NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, F...

L&T Technology Services

L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 52 Fortune 500 companies and 51 of the world’s top ER&D companies, acro...

International PBI S.p.A

International Pbi is recognized in Italy as the leading supplier for chemical-physical analyses and microbiological research products as well as products for laboratory research.The most important customers in Italy are laboratories for analysis, pharmaceutical companies, chemist, biotechnologist and public structures such as Universities.There are more than 30.000 different articles regarding the...

GlysBy Diagnostics

arket, with the aim to offer to both our manufacturing partners and customers a new and easier way to make business. GlysBy creates new business opportunities for and with its partners, acting as an International Marketing & Sales Office representing them, looking at wholesalers, distributors and OEM customers, devising strategies to enter new markets, and much more. GlysBy extensively...

Genzyme Genetics

Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services. As a business unit of Genzyme Corporation, Genzyme Genetics employs over 1,500 people and has eight laboratories located across the United States and operations in Europe and Japan. Extensive Test MenuGenzyme Genetics leadership is evidenced by its state-of-the-...

M-Medical S.r.l.

M-Medical was established in 1981 as a diagnostic and research products distributor to the clinical and research laboratory market in Italy. M-Medical is owned by D-Group and operates in Italy exclusively in the area of "Life Sciences" products for research laboratories. M-Medical is the Italian leader in the molecular biology, genetics and cell biology business. We are proud to say that we have p...

Medcomtech

Medcomtech is a company created in 2002 which aims to provide a platform for introducing technologically advanced products in the areas of orthopedics, traumatology and neurosurgery in Spain, Portugal and Italy. In March 2010, Medcomtech was launched in the MAB (Alternative Investment Market), a market for SMEs and in 2011 created two new subsidiaries in Portugal and Italy. Today Medcomtech ...

Genetic Technologies

Our company is a leading-edge Australian life science company, specialising in genetics and genomics. We owe our success to being a global pioneer in recognising the importance of 'non-coding' DeoxyriboNucleic Acid (DNA). This research discovery enabled us to patent strategies by which non-coding variation in the DNA is utilised to analyse genetic material and also to map genes and traits of i...

Cowen Group Inc.

Cowen Group, Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, and sales and trading services through its two business segments: Ramius and its affiliates make up the Company’s alternative investment segment, while Cowen and Company and i...

Provista Diagnostics, Inc.

Provista Diagnostics, Inc., a Delaware company, develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. The company's focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near term development and commercializatio...


More From BioPortfolio on "2018 Italy Oncology Testing Market Shares Sales Segment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks